New-onset atrial fibrillation (NOAF) may develop following coronary artery bypass grafting (CABG), but is extremely rare after percutaneous coronary intervention (PCI), among patients with left main coronary artery disease (LMCAD) undergoing revascularization in the EXCEL* trial, according to a study. Furthermore, NOAF development is strongly associated with subsequent death and stroke in CABG-treated patients.
A recent study has identified readily accessible risk factors linked to the occurrence of stroke and merged these in an easy-to-use risk score. This score may be used to identify patients with myocardial infarction (MI) and heart failure (HF) and an elevated risk for stroke despite their not presenting with atrial fibrillation (AF).
Life-threatening complications occur in nearly one in five patients admitted to the hospital with aortic stenosis despite active monitoring in more than half of such patients for the said disorder prior to admission, a recent study has found.
Risks of infection, but not malignancy, are greater in diabetic than nondiabetic immunosuppressed individuals who underwent renal transplantation and may play a bigger role in the excess mortality populations than previously held, a recent study has found. However, the rate of noncardiovascular death in nondiabetic persons also exceeds cardiovascular deaths.
Height-adjusted mean common carotid artery diameter (CCA-D) appears to be an independent predictor of individual target organ damage (TOD), including left ventricular mass index (LVMI), pulse wave velocity (PWV) and urinary albumin/creatinine ratio, as well as overall number of TODs in essential hypertension, according to a study.
In patients admitted for cardiac surgery, preoperative levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) are affected by underlying heart diseases which, in turn, affect its predictive value for severe postoperative heart failure (SPHF), a recent study has shown.
In adults with repaired tetralogy of Fallot, high-intensity interval training is effective in improving quality of life, vascular function, exercise capacity, fibrinogen levels and N-terminal pro-brain natriuretic peptide levels, according to a recent study.
Treatment with nebivolol in asymptomatic individuals with prehypertension or borderline blood pressure (BP) provides superior improvements in small artery function compared with atenolol in spite of their similar BP-lowering effect, a study has found.
Red yeast rice extracts have been used in traditional medicine for centuries.1 In recent times, an extract from red yeast rice, Xuezhikang® (XZK), has been studied for its role in dyslipidaemia and cardiovascular disease. This review will look at some of the clinical trials that have done so.